#lymphoma

Many cancer patients eligible for CAR-T therapy must live away from home for several months while they complete treatment.

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

The first two people treated with the “living drug” remained cancer-free for a decade and can be considered cured.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

Carcinogenic air pollution is often concentrated in communities of color.

The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.

Could these everyday skin problems be a symptom of an underlying health condition?

Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.

Those with blood cancers are nine times more likely to be hospitalized or die from the flu.

Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.

Scientists plan to develop interventions that use social networks to improve the health outcomes of cancer survivors.

The cause may be an abnormal immune response the body launches against the foreign material inserted into the breast tissue.